Please select the option that best describes you:
Topics:
Gynecologic Cancers • Cervical Cancer • Medical Oncology • Immunotherapy • ASCO Journal Club
Would you recommend 1st line pembrolizumab for PD-L1 positive recurrent/metastatic cervical cancer patient who is not a candidate for or refuses chemotherapy?
Answer from: at Academic Institution
No. First-line pembrolizumab has not yet been approved for that indication in cervical cancer. It is being studied in Keynote-826.
Sign in or Register to read more